Exploratory CSF proteomics biomarker outcomes of the the phase 2 clinical trial shine to assess the effects of CT1812 in Alzheimer’s patients

Valentina Di Caro, Britney N Lizama, Eunah Cho, Duc M Duong, Kiran Pandey, Kaj Blennow, Henrik Zetterberg, Allan I Levey, Charlotte Teunissen, Anthony O Caggiano, Nicholas T Seyfried, Mary E Hamby · 2025

Read Exploratory CSF proteomics biomarker outcomes of the the phase 2 clinical trial shine to assess the effects of CT1812 in Alzheimer’s patients by Valentina Di Caro, Britney N Lizama, Eunah Cho, Duc M Duong, Kiran Pandey, Kaj Blennow, Henrik Zetterberg, Allan I Levey, Charlotte Teunissen, Anthony O Caggiano, Nicholas T Seyfried, Mary E Hamby (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714057.txt.

Description

Di Caro and co-authors report in 2025 spinal fluid protein results from the SHINE phase 2 trial of the drug CT1812 in Alzheimer's disease. The trial randomized patients with mild to moderate disease to placebo or one of two daily doses for six months. Fluid samples came from 47 people who finished the study.

Mass spectrometry measured protein change from baseline in each person. Drug versus placebo contrasts then hunted engagement and disease markers. Brain network mapping and pathway tools framed the hits, and protein levels were correlated with core disease biomarkers. An interim look at the first 24 patients starts the report's results.

Catalog record

CREATORValentina Di Caro, Britney N Lizama, Eunah Cho, Duc M Duong, Kiran Pandey, Kaj Blennow, Henrik Zetterberg, Allan I Levey, Charlotte Teunissen, Anthony O Caggiano, Nicholas T Seyfried, Mary E Hamby
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11714057

Browse the full library · About the Tower of Babel